1/16
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Antibodies/Ig
Glycoproteins produced by B-lineage cells
Membrane-bound Ig
Serves as B-cell receptor
Secreted Ig (antibody)
Produced by plasma cells
Heavy chains
Determines antibody class
Light chains
Either 2 k or 2 a light chains
Does not determine class
Antibody specificity
Determined by variable regions of both heavy and light chains
IgG
Most abundant in blood
Neutralizes, opsonizes, and activates classical pathway
Important in secondary immune responses
Crosses placenta and provides passive immunity to fetus
IgA
Mucosal immunity
Monomer form in blood
Dimer form joined by J chain found in mucosal secretions
Provides passive immunity to newborns via breast milk
IgM
First antibody in a primary response
Monomer form expressed as BCR with IgD
Pentamer form joined by J chain is secreted
Early IgM has lower affinity, while later pentamer has high avidity
IgE
Allergy and parasite defense, binds mast cells
IgD
Functions as BCR on B cells
Primary response
First exposure
Slower and weaker
Activates naive B cells w/ CD4 helper T cell
IgM produced first, then later class switchingS
Secondary Response
Driven by memory B cells
Faster, stronger, longer-lasting
Usually IgG high-affinity antibodies
RhIG/RhoGAM
Preformed anti-D antibodies
Given to unsensitized Rh- mothers during pregnancy to prevent sensitizationA
Adoptive Cellular Therapy
Transfer of immune cells into patient to enhance immune response
CAR T-cell therapy
patient's T cells are genetically engineered to recognize a tumor antigen
Tumor-Infiltrating Lymphocytes Therapy
T cells are isolated from the patient's tumor, expanded outside the body, reinfused